Medical - Devices
Compare Stocks
4 / 10Stock Comparison
KIDS vs ZBH vs SYK vs ATEC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Medical - Devices
Medical - Devices
KIDS vs ZBH vs SYK vs ATEC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Medical - Devices | Medical - Devices | Medical - Devices |
| Market Cap | $444M | $16.32B | $112.69B | $1.17B |
| Revenue (TTM) | $243M | $8.41B | $25.12B | $595M |
| Net Income (TTM) | $-40M | $761M | $3.25B | $-125M |
| Gross Margin | 73.1% | 70.0% | 63.5% | 89.6% |
| Operating Margin | -12.1% | 15.6% | 22.4% | -9.6% |
| Forward P/E | — | 9.8x | 19.6x | 24.1x |
| Total Debt | $100M | $7.52B | $14.86B | $620M |
| Cash & Equiv. | $20M | $592M | $4.01B | $161M |
KIDS vs ZBH vs SYK vs ATEC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| OrthoPediatrics Cor… (KIDS) | 100 | 38.6 | -61.4% |
| Zimmer Biomet Holdi… (ZBH) | 100 | 67.2 | -32.8% |
| Stryker Corporation (SYK) | 100 | 145.8 | +45.8% |
| Alphatec Holdings, … (ATEC) | 100 | 169.0 | +69.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KIDS vs ZBH vs SYK vs ATEC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KIDS lags the leaders in this set but could rank higher in a more targeted comparison.
ZBH carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.65, Low D/E 59.2%, current ratio 1.98x
- Beta 0.65, yield 1.1%, current ratio 1.98x
- Lower P/E (9.8x vs 24.1x)
- 1.1% yield, vs SYK's 1.1%, (2 stocks pay no dividend)
SYK is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 34 yrs, beta 0.55, yield 1.1%
- 187.1% 10Y total return vs ATEC's 225.4%
- 12.9% margin vs ATEC's -21.1%
- Beta 0.55 vs KIDS's 1.41
ATEC is the clearest fit if your priority is growth exposure.
- Rev growth 25.0%, EPS growth 15.0%, 3Y rev CAGR 29.6%
- 25.0% revenue growth vs ZBH's 7.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 25.0% revenue growth vs ZBH's 7.2% | |
| Value | Lower P/E (9.8x vs 24.1x) | |
| Quality / Margins | 12.9% margin vs ATEC's -21.1% | |
| Stability / Safety | Beta 0.55 vs KIDS's 1.41 | |
| Dividends | 1.1% yield, vs SYK's 1.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | -10.4% vs ATEC's -37.8% | |
| Efficiency (ROA) | 6.9% ROA vs ATEC's -15.8%, ROIC 11.4% vs -12.6% |
KIDS vs ZBH vs SYK vs ATEC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
KIDS vs ZBH vs SYK vs ATEC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SYK leads in 3 of 6 categories
ZBH leads 1 • KIDS leads 0 • ATEC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SYK leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SYK is the larger business by revenue, generating $25.1B annually — 103.2x KIDS's $243M. SYK is the more profitable business, keeping 12.9% of every revenue dollar as net income compared to ATEC's -21.1%. On growth, KIDS holds the edge at +13.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $243M | $8.4B | $25.1B | $595M |
| EBITDAEarnings before interest/tax | -$13M | $2.3B | $6.3B | $4M |
| Net IncomeAfter-tax profit | -$40M | $761M | $3.2B | -$125M |
| Free Cash FlowCash after capex | -$13M | $1.8B | $4.3B | $7M |
| Gross MarginGross profit ÷ Revenue | +73.1% | +70.0% | +63.5% | +89.6% |
| Operating MarginEBIT ÷ Revenue | -12.1% | +15.6% | +22.4% | -9.6% |
| Net MarginNet income ÷ Revenue | -16.3% | +9.1% | +12.9% | -21.1% |
| FCF MarginFCF ÷ Revenue | -5.2% | +21.8% | +17.1% | +1.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.3% | +9.3% | +11.4% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.2% | +34.1% | +56.0% | +37.1% |
Valuation Metrics
ZBH leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 23.5x trailing earnings, ZBH trades at a 33% valuation discount to SYK's 35.0x P/E. On an enterprise value basis, ZBH's 9.5x EV/EBITDA is more attractive than ATEC's 3752.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $444M | $16.3B | $112.7B | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $525M | $23.3B | $123.5B | $1.6B |
| Trailing P/EPrice ÷ TTM EPS | -10.40x | 23.48x | 35.03x | -8.07x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 9.83x | 19.62x | 24.13x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.36x | — |
| EV / EBITDAEnterprise value multiple | — | 9.47x | 20.31x | 3752.09x |
| Price / SalesMarket cap ÷ Revenue | 1.88x | 1.98x | 4.49x | 1.54x |
| Price / BookPrice ÷ Book value/share | 1.19x | 1.30x | 5.02x | 32.28x |
| Price / FCFMarket cap ÷ FCF | — | 11.09x | 26.31x | 422.56x |
Profitability & Efficiency
SYK leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
SYK delivers a 15.0% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-4 for ATEC. KIDS carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to ATEC's 17.21x. On the Piotroski fundamental quality scale (0–9), SYK scores 6/9 vs KIDS's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -11.4% | +5.8% | +15.0% | -4.4% |
| ROA (TTM)Return on assets | -7.9% | +3.3% | +6.9% | -15.8% |
| ROICReturn on invested capital | -5.3% | +5.4% | +11.4% | -12.6% |
| ROCEReturn on capital employed | -6.4% | +6.9% | +13.0% | -13.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.29x | 0.59x | 0.66x | 17.21x |
| Net DebtTotal debt minus cash | $80M | $6.9B | $10.8B | $459M |
| Cash & Equiv.Liquid assets | $20M | $592M | $4.0B | $161M |
| Total DebtShort + long-term debt | $100M | $7.5B | $14.9B | $620M |
| Interest CoverageEBIT ÷ Interest expense | -5.55x | 4.08x | 6.72x | -3.29x |
Total Returns (Dividends Reinvested)
SYK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SYK five years ago would be worth $12,152 today (with dividends reinvested), compared to $2,738 for KIDS. Over the past 12 months, ZBH leads with a -10.4% total return vs ATEC's -37.8%. The 3-year compound annual growth rate (CAGR) favors SYK at 1.8% vs KIDS's -27.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.1% | -7.1% | -15.2% | -62.7% |
| 1-Year ReturnPast 12 months | -20.8% | -10.4% | -22.5% | -37.8% |
| 3-Year ReturnCumulative with dividends | -62.0% | -37.2% | +5.5% | -47.8% |
| 5-Year ReturnCumulative with dividends | -72.6% | -47.3% | +21.5% | -48.7% |
| 10-Year ReturnCumulative with dividends | -8.6% | -17.8% | +187.1% | +225.4% |
| CAGR (3Y)Annualised 3-year return | -27.6% | -14.4% | +1.8% | -19.5% |
Risk & Volatility
Evenly matched — ZBH and SYK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SYK is the less volatile stock with a 0.55 beta — it tends to amplify market swings less than KIDS's 1.41 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ZBH currently trades 77.0% from its 52-week high vs ATEC's 33.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.41x | 0.60x | 0.52x | 0.74x |
| 52-Week HighHighest price in past year | $23.70 | $108.29 | $404.87 | $23.29 |
| 52-Week LowLowest price in past year | $14.42 | $79.83 | $289.91 | $6.85 |
| % of 52W HighCurrent price vs 52-week peak | +74.1% | +77.0% | +72.7% | +33.3% |
| RSI (14)Momentum oscillator 0–100 | 58.1 | 34.3 | 24.3 | 26.8 |
| Avg Volume (50D)Average daily shares traded | 171K | 2.2M | 2.1M | 3.0M |
Analyst Outlook
Evenly matched — ZBH and SYK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: KIDS as "Buy", ZBH as "Hold", SYK as "Buy", ATEC as "Buy". Consensus price targets imply 154.3% upside for ATEC (target: $20) vs 17.4% for ZBH (target: $98). For income investors, ZBH offers the higher dividend yield at 1.15% vs SYK's 1.14%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $21.00 | $97.90 | $403.69 | $19.71 |
| # AnalystsCovering analysts | 13 | 42 | 50 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | +1.1% | +1.1% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | 34 | — |
| Dividend / ShareAnnual DPS | — | $0.96 | $3.36 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.0% | 0.0% | 0.0% |
SYK leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ZBH leads in 1 (Valuation Metrics). 2 tied.
KIDS vs ZBH vs SYK vs ATEC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is KIDS or ZBH or SYK or ATEC a better buy right now?
For growth investors, Alphatec Holdings, Inc.
(ATEC) is the stronger pick with 25. 0% revenue growth year-over-year, versus 7. 2% for Zimmer Biomet Holdings, Inc. (ZBH). Zimmer Biomet Holdings, Inc. (ZBH) offers the better valuation at 23. 5x trailing P/E (9. 8x forward), making it the more compelling value choice. Analysts rate OrthoPediatrics Corp. (KIDS) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KIDS or ZBH or SYK or ATEC?
On trailing P/E, Zimmer Biomet Holdings, Inc.
(ZBH) is the cheapest at 23. 5x versus Stryker Corporation at 35. 0x. On forward P/E, Zimmer Biomet Holdings, Inc. is actually cheaper at 9. 8x.
03Which is the better long-term investment — KIDS or ZBH or SYK or ATEC?
Over the past 5 years, Stryker Corporation (SYK) delivered a total return of +21.
5%, compared to -72. 6% for OrthoPediatrics Corp. (KIDS). Over 10 years, the gap is even starker: ATEC returned +215. 7% versus ZBH's -18. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KIDS or ZBH or SYK or ATEC?
By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.
52β versus OrthoPediatrics Corp. 's 1. 41β — meaning KIDS is approximately 170% more volatile than SYK relative to the S&P 500. On balance sheet safety, OrthoPediatrics Corp. (KIDS) carries a lower debt/equity ratio of 29% versus 17% for Alphatec Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — KIDS or ZBH or SYK or ATEC?
By revenue growth (latest reported year), Alphatec Holdings, Inc.
(ATEC) is pulling ahead at 25. 0% versus 7. 2% for Zimmer Biomet Holdings, Inc. (ZBH). On earnings-per-share growth, the picture is similar: Alphatec Holdings, Inc. grew EPS 15. 0% year-over-year, compared to -19. 9% for Zimmer Biomet Holdings, Inc.. Over a 3-year CAGR, ATEC leads at 29. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — KIDS or ZBH or SYK or ATEC?
Stryker Corporation (SYK) is the more profitable company, earning 12.
9% net margin versus -18. 8% for Alphatec Holdings, Inc. — meaning it keeps 12. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SYK leads at 19. 5% versus -12. 3% for KIDS. At the gross margin level — before operating expenses — KIDS leads at 73. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is KIDS or ZBH or SYK or ATEC more undervalued right now?
On forward earnings alone, Zimmer Biomet Holdings, Inc.
(ZBH) trades at 9. 8x forward P/E versus 24. 1x for Alphatec Holdings, Inc. — 14. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ATEC: 154. 3% to $19. 71.
08Which pays a better dividend — KIDS or ZBH or SYK or ATEC?
In this comparison, ZBH (1.
1% yield), SYK (1. 1% yield) pay a dividend. KIDS, ATEC do not pay a meaningful dividend and should not be held primarily for income.
09Is KIDS or ZBH or SYK or ATEC better for a retirement portfolio?
For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
52), 1. 1% yield, +179. 2% 10Y return). Both have compounded well over 10 years (SYK: +179. 2%, KIDS: -7. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between KIDS and ZBH and SYK and ATEC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: KIDS is a small-cap high-growth stock; ZBH is a mid-cap quality compounder stock; SYK is a mid-cap quality compounder stock; ATEC is a small-cap high-growth stock. ZBH, SYK pay a dividend while KIDS, ATEC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.